PolyPeptide Group AG (XSWX:PPGN) Days Sales Outstanding : 70.70 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Days Sales Outstanding?

PolyPeptide Group AG's average Accounts Receivable for the six months ended in Dec. 2023 was CHF68.9 Mil. PolyPeptide Group AG's Revenue for the six months ended in Dec. 2023 was CHF177.8 Mil. Hence, PolyPeptide Group AG's Days Sales Outstanding for the six months ended in Dec. 2023 was 70.70.

The historical rank and industry rank for PolyPeptide Group AG's Days Sales Outstanding or its related term are showing as below:

XSWX:PPGN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.73 Med: 73.22 Max: 86.12
Current: 72.92

During the past 6 years, PolyPeptide Group AG's highest Days Sales Outstanding was 86.12. The lowest was 69.73. And the median was 73.22.

XSWX:PPGN's Days Sales Outstanding is ranked worse than
50.8% of 998 companies
in the Drug Manufacturers industry
Industry Median: 72.035 vs XSWX:PPGN: 72.92

PolyPeptide Group AG's Days Sales Outstanding increased from Dec. 2022 (59.53) to Dec. 2023 (70.70).

PolyPeptide Group AG Days Sales Outstanding Historical Data

The historical data trend for PolyPeptide Group AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Days Sales Outstanding Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

69.73

71.57

78.14

74.87

71.39

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial					70.23	77.79	59.53	78.99	70.70

Competitive Comparison of PolyPeptide Group AG's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, PolyPeptide Group AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PolyPeptide Group AG's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PolyPeptide Group AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PolyPeptide Group AG's Days Sales Outstanding falls into.

PolyPeptide Group AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PolyPeptide Group AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (45.875	+	72.309)	/	2 )	/	302.135	*	365
=	59.092					/	302.135	*	365
=	71.39

PolyPeptide Group AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (65.457	+	72.309)	/	2 )	/	177.806	*	365 / 2
=	68.883					/	177.806	*	365 / 2
=	70.70

PolyPeptide Group AG (XSWX:PPGN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

PolyPeptide Group AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines